Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
Authors
Keywords
Gut microbiome, Hepatocellular carcinoma, Anti-PD-1 immunotherapy
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-23
DOI
10.1186/s40425-019-0650-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- A metagenomic study of the gut microbiome in Behcet’s disease
- (2018) Zi Ye et al. Microbiome
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients
- (2017) Jessica R. Galloway-Peña et al. Genome Medicine
- Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing
- (2017) Chao Fang et al. GigaScience
- Methane limit LPS-induced NF-κB/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K/AKT/GSK-3β-mediated IL-10 expression
- (2016) Xu Zhang et al. Scientific Reports
- Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome
- (2015) Saeed Shoaie et al. Cell Metabolism
- MetaPhlAn2 for enhanced metagenomic taxonomic profiling
- (2015) Duy Tin Truong et al. NATURE METHODS
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- An integrated catalog of reference genes in the human gut microbiome
- (2014) Junhua Li et al. NATURE BIOTECHNOLOGY
- The UCSC Genome Browser database: 2015 update
- (2014) Kate R. Rosenbloom et al. NUCLEIC ACIDS RESEARCH
- The Long-Term Stability of the Human Gut Microbiota
- (2013) J. J. Faith et al. SCIENCE
- From meta-omics to causality: experimental models for human microbiome research
- (2013) Joëlle V Fritz et al. Microbiome
- Measures of phylogenetic differentiation provide robust and complementary insights into microbial communities
- (2012) Donovan H Parks et al. ISME Journal
- Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
- (2011) G. D. Wu et al. SCIENCE
- Metagenomic biomarker discovery and explanation
- (2011) Nicola Segata et al. GENOME BIOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started